These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 17096297
1. New macrolides. Dalziel C, Turner B. IDrugs; 2006 Nov; 9(11):771-3. PubMed ID: 17096297 [No Abstract] [Full Text] [Related]
2. Interscience conference on antimicrobial agents and chemotherapy--46th annual meeting. Release of data for Dc-159a, and other agents. 27-30 September 2006, San Francisco, CA, USA. Dalziel C, Turner B. IDrugs; 2006 Nov; 9(11):765-7. PubMed ID: 17096295 [No Abstract] [Full Text] [Related]
3. Interscience Conference on Antimicrobial Agents and Chemotherapy--46th annual meeting. 27-30 September 2006, San Francisco, CA, USA. Turner B. IDrugs; 2006 Nov; 9(11):761-4. PubMed ID: 17096294 [No Abstract] [Full Text] [Related]
4. Interscience conference on antimicrobial agents and chemotherapy--46th annual meeting. New oxazolidinone antibiotics by Wockhardt and Kyorin. 27-30 September 2006, San Francisco, CA, USA. Dalziel C. IDrugs; 2006 Nov; 9(11):768-70. PubMed ID: 17096296 [No Abstract] [Full Text] [Related]
5. Interscience Conference on Antimicrobial Agents and Chemotherapy--48th Annual Meeting and Infectious Diseases Society of America-- 46th Annual Meeting Updates on therapeutic research--Part 2. Sovran L. IDrugs; 2009 Jan; 12(1):3-4. PubMed ID: 19127493 [No Abstract] [Full Text] [Related]
9. Molecule of the month. LBM-415. Drug News Perspect; 2005 Sep; 18(1):46. PubMed ID: 15753974 [No Abstract] [Full Text] [Related]
10. Drug discovery conference 2008. Small-Molecule Drug Discovery: From Early Stage to the Clinic. Terrett NK. IDrugs; 2008 Mar; 11(3):164-8. PubMed ID: 18311648 [No Abstract] [Full Text] [Related]
11. Novelties in the field of anti-infectives in 1998. Bryskier A. Clin Infect Dis; 1999 Sep; 29(3):632-58. PubMed ID: 10530460 [Abstract] [Full Text] [Related]
12. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators. Giamarellos-Bourboulis EJ. Int J Antimicrob Agents; 2008 Jan; 31(1):12-20. PubMed ID: 17935949 [Abstract] [Full Text] [Related]
13. Recent progress regarding the bioactivities, biosynthesis and synthesis of naturally occurring resorcinolic macrolides. Xu J, Jiang CS, Zhang ZL, Ma WQ, Guo YW. Acta Pharmacol Sin; 2014 Mar; 35(3):316-30. PubMed ID: 24464049 [Abstract] [Full Text] [Related]
14. Looking for new preparations for antibacterial therapy. IV. New antimicrobial agents from the aminoglycoside, macrolide and tetracycline groups in clinical trials. Karpiuk I, Tyski S. Przegl Epidemiol; 2015 Mar; 69(4):723-9, 865-70. PubMed ID: 27139351 [Abstract] [Full Text] [Related]
15. Metabolic diseases. Balfe A, Perry L. IDrugs; 2006 Nov; 9(11):754-5. PubMed ID: 17096291 [No Abstract] [Full Text] [Related]
16. Synthesis, structure and biological activity of pseudopeptidic macrolides based on an amino alcohol. Lv J, Liu T, Wang Y. Eur J Med Chem; 2008 Jan; 43(1):19-24. PubMed ID: 17507115 [Abstract] [Full Text] [Related]
17. Asian Pacific Society of Respirology--tenth congress and first joint congress with the American College of Chest Physicians. 11-14 November 2005, Guangzhou, China. Seale JP. IDrugs; 2006 Jan; 9(1):23-4. PubMed ID: 16374727 [No Abstract] [Full Text] [Related]
18. Cellular and molecular effects of macrolides on leukocyte function. Labro MT. Curr Pharm Des; 2004 Jan; 10(25):3067-80. PubMed ID: 15544498 [Abstract] [Full Text] [Related]
19. [Antifungals for systemic use]. Ruiz-Camps I, Cuenca-Estrella M. Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):353-62. PubMed ID: 19482382 [Abstract] [Full Text] [Related]
20. The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases. Eraković Haber V, Bosnar M, Kragol G. Future Med Chem; 2014 Apr; 6(6):657-74. PubMed ID: 24895894 [Abstract] [Full Text] [Related] Page: [Next] [New Search]